Abano Healthcare Group Ltd (ABA)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Abano Healthcare Group Ltd (ABA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013173
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ニュージーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abano Healthcare Group Ltd (Abano Healthcare), formerly ElderCare New Zealand Ltd is a healthcare service provider that offers Dental, Audiology, Radiology and medical services. The company also operates business in community pathology and radiology sector. It operates businesses in sectors of the healthcare markets such as abano audiology, abano dental and abano diagnostics, among others. Abano healthcare‘s insight and ascot radiology offers high quality digitial imaging and radiology services across modalities, including digital breast mammography, PET CT scanning, CT, MRI and 4D obstetric ultrasound, among others. The company has its presence in Auckland, Wellington, Royal Oak, Parnell, Albert St and Southport, among others. Abano healthcare is headquartered in Auckland, New Zealand.

Abano Healthcare Group Ltd (ABA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Abano Healthcare Group Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Abano Healthcare Announces Private Placement Of Shares 10
Abano Healthcare Announces Rights Offering Of Shares 11
Acquisition 12
Bupa Care Services Completes Acquisition Of Abano Rehabilitation From Abano Healthcare 12
Abano Healthcare Completes Acquisition Of Remaining 30% Stake In Dental Partners For US$14 Million 13
Abano Healthcare Group Ltd – Key Competitors 14
Abano Healthcare Group Ltd – Key Employees 15
Abano Healthcare Group Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Nov 15, 2017: HY18 Guidance for six months to 30 November 2017 17
Jul 26, 2017: Abano FY17 Full Year Results Announcement 18
Jul 27, 2016: ABA FY16 Results and Increased Dividend 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Abano Healthcare Group Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Abano Healthcare Announces Private Placement Of Shares 10
Abano Healthcare Announces Rights Offering Of Shares 11
Bupa Care Services Completes Acquisition Of Abano Rehabilitation From Abano Healthcare 12
Abano Healthcare Completes Acquisition Of Remaining 30% Stake In Dental Partners For US$14 Million 13
Abano Healthcare Group Ltd, Key Competitors 14
Abano Healthcare Group Ltd, Key Employees 15
Abano Healthcare Group Ltd, Other Locations 16
Abano Healthcare Group Ltd, Subsidiaries 16

★海外企業調査レポート[Abano Healthcare Group Ltd (ABA)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Microvision Inc (MVIS):企業の財務・戦略的SWOT分析
    Summary Microvision Inc (Microvision) is a technology company that provides scanning technology solutions. The company offers technology solutions including PicoP scanning technology, an ultra-miniature laser projection and imaging solutions based on the laser beam scanning methodology. It also prov …
  • Tethys Oil AB (TETY):石油・ガス:M&Aディール及び事業提携情報
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds 2P reserves of 21.4 mmbo and has an oil production of barrels from Blocks in Sultanate of Oman. It also holds onshore explorati …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512):企業の財務・戦略的SWOT分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is a manufacturer of medical devices. The company develops, manufactures and distributes pharmaceutical preparations, medical devices pharmaceutical intermediates, specialized raw materials, and healthcare products. It also …
  • Thales Deutschland GmbH:企業の戦略・SWOT・財務情報
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Varian Medical Systems Inc (VAR):企業の財務・戦略的SWOT分析
    Varian Medical Systems Inc (VAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Arch Pharmalabs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Arch Pharmalabs Ltd (Arch Pharmalabs) is a healthcare products company that offers pharmaceutical ingredients. The company manufactures, develops and markets active APIs and intermediates to innovator and generic pharmaceutical players. It offers products such as docetaxel anhydrous and trih …
  • Cosmo Oil Co., Ltd.:企業の戦略・SWOT・財務分析
    Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Advantest Corporation (6857):企業の財務・戦略的SWOT分析
    Advantest Corporation (6857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Air Liquide Welding France, S.A.:企業の戦略・SWOT・財務情報
    Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report Summary Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • BIND Therapeutics Inc (BIND)-製薬・医療分野:企業M&A・提携分析
    Summary BIND Therapeutics Inc (BIND Therapeutics) is a nanomedicine platform company that develops and commercializes preclinical candidates for cardiovascular disease, cancer and inflammatory disease. The company’s pipeline products include BIND-014, an Accurin that contains the well-established ch …
  • Waters Corporation (WAT)-医療機器分野:企業M&A・提携分析
    Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatograp …
  • Universal Music Group Inc:企業の戦略的SWOT分析
    Universal Music Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Allinky Biopharma SL:医療機器:M&Aディール及び事業提携情報
    Summary Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and discovery of novel therapies. Its therapeutic agents comprise active site drugs, target prote …
  • Tipco Asphalt Public Company Limited:企業の戦略・SWOT・財務情報
    Tipco Asphalt Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Tipco Asphalt Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Centrexion Therapeutics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975, CNTX- 0290, CNTX-6970, CNTX-2022, CNTX-6016 and Intrathecalplatform. Its …
  • Vattenfall AB.:企業の戦略・SWOT・財務分析
    Vattenfall AB. - Strategy, SWOT and Corporate Finance Report Summary Vattenfall AB. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Technical University of Denmark:製薬・医療:M&Aディール及び事業提携情報
    Summary Technical University of Denmark (DTU) is an educational and research service provider. The university offers undergraduate programs, graduate programs, PhD programs, BSc programs, MSc programs, guest student services, accommodation services and others. It conducts research programs in the ar …
  • StemBioSys Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary StemBioSys Inc (StemBioSys) is a biomedical company that concentrates on isolation, expansion and delivery of specialized adult stem cells. The company has developed high performance microenvironment for treating human diseases. Its HPME is an advanced stem cell culture system that creates n …
  • Achema AB:企業の戦略的SWOT分析
    Achema AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆